Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: gtglabs.com (GENE)

Genetic Technologies Limited - logo grafis emiten GENE

This quarterly earnings per share chart demonstrates the financial dynamics of Genetic Technologies (GENE), where the value 39.40 captures the metric level. Genetic Technologies aims to implement PRS tests for the early diagnosis of cancer and heart disease. These innovations are based on AI DNA analysis algorithms for preventive medicine, while cloud IT services are delegated to external partners under strict adherence to security protocols.

gtglabs.com (GENE) - Wutah bathi resik saben saham sajroning taun lumaku saka 04.07.2022 nganti 26.10.2024
Produk asil prodhuksi Genetic Technologies

To distinguish a sustainable business from speculative capital, analyzing the dynamics of net earnings per share is critical, as it measures the real pace of value generation per ownership stake. The quarterly percentage change in EPS allows for an assessment of how the digital genetic testing ecosystem and B2B integration with the AI platform mitigate market risks, confirming the fundamental viability of the Genetic Technologies (GENE) model during periods of economic contraction.

Analisis pesaing Genetic Technologies

A: Wutah bathi EPS kuartalan|DGX - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Illumina Corp|Exact Sciences Inc. (EXAS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan RVTY|bio-rad.com (BIO) - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan NNNN (Anbio)|Sotera Health Corp (SHC) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|QDEL - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|OPK (OPKO Health Corp.) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|CDNA: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan maravai.com (MRVI)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan FLGT|LAB (Standard BioTools Inc) - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan CTKB|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan OraSure Corp|Wutah bathi EPS kuartalan XGN (Exagen)|MDXH - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|LUCD: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PRE (Prenetics Global)|IMDX (imdxinc.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|TRIB: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|PRPH (ProPhase Labs, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ainos.com AIMD|Wutah bathi EPS kuartalan CODX|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Heart Test Laboratories, Inc. HSCS|Wutah bathi EPS kuartalan BMRA (Biomerica, Inc)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan CDIO|ONCO - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|VRAX (viraxbiolabs.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Bluejay Diagnostics, Inc. (BJDX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aspira Women's Health, Inc. (AWH)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Accelerate Diagnostics, Inc|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CNTG|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Enzo Biochem, Inc. (ENZ)|FRES - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan ME (23andMe)|Wutah bathi resik saben saham sajroning taun lumaku Psychemedics Corp.